| SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 Q Lu, J Liu, S Zhao, MFG Castro, M Laurent-Rolle, J Dong, X Ran, ... Immunity 54 (6), 1304-1319. e9, 2021 | 132 | 2021 |
| Siglec-15 as an emerging target for next-generation cancer immunotherapy J Sun, Q Lu, MF Sanmamed, J Wang Clinical Cancer Research 27 (3), 680-688, 2021 | 93 | 2021 |
| Quantitating endosomal escape of a library of polymers for mRNA delivery Y Jiang, Q Lu, Y Wang, E Xu, A Ho, P Singh, Y Wang, Z Jiang, F Yang, ... Nano letters 20 (2), 1117-1123, 2020 | 69 | 2020 |
| Deglycosylation-dependent fluorescent proteins provide unique tools for the study of ER-associated degradation JE Grotzke, Q Lu, P Cresswell Proceedings of the National Academy of Sciences 110 (9), 3393-3398, 2013 | 62 | 2013 |
| The ongoing saga of the mechanism (s) of MHC class I-restricted cross-presentation JE Grotzke, D Sengupta, Q Lu, P Cresswell Current opinion in immunology 46, 89-96, 2017 | 61 | 2017 |
| Mechanical activation of spike fosters SARS-CoV-2 viral infection W Hu, Y Zhang, P Fei, T Zhang, D Yao, Y Gao, J Liu, H Chen, Q Lu, ... Cell Research 31 (10), 1047-1060, 2021 | 36 | 2021 |
| A novel probe to assess cytosolic entry of exogenous proteins Q Lu, JE Grotzke, P Cresswell Nature Communications 9 (1), 3104, 2018 | 21 | 2018 |
| A membrane-associated MHC-I inhibitory axis for cancer immune evasion X Chen, Q Lu, H Zhou, J Liu, B Nadorp, A Lasry, Z Sun, B Lai, G Rona, ... Cell 186 (18), 3903-3920. e21, 2023 | 20 | 2023 |
| Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine K He, T Wan, D Wang, J Hu, T Zhou, W Tao, Z Wei, Q Lu, R Zhou, Z Tian, ... Cell 186 (14), 3033-3048. e20, 2023 | 19 | 2023 |
| Myeloid dysregulation and therapeutic intervention in COVID-19 R Gu, T Mao, Q Lu, TT Su, J Wang Seminars in immunology 55, 101524, 2021 | 9 | 2021 |
| Targeting MHC-I inhibitory pathways for cancer immunotherapy J Wang, Q Lu, X Chen, I Aifantis Trends in Immunology, 2024 | | 2024 |
| A membrane-associated inhibitory axis of MHC-I presentation for cancer immune evasion Q Lu, X Chen, H Zhou, J Liu, B Nadorp, A Lasry, Z Sun, J Zhang, ... The Journal of Immunology 210 (1_Supplement), 89.12-89.12, 2023 | | 2023 |
| Abstract A10: Targeting MHC-I antigen presentation for cancer immune evasion in acute myeloid leukemia X Chen, Q Lu, H Zhou, J Liu, B Nadorp, A Lasry, Z Sun, J Zhang, ... Blood Cancer Discovery 4 (3_Supplement), A10-A10, 2023 | | 2023 |
| Drug Design X Chen, Q Lu, H Zhou, J Liu, B Nadorp, A Lasry Cell 186, 3903-20, 2023 | | 2023 |
| A novel probe to assess cytosolic entry of exogenous proteins Q Lu, Y Jiang, J Grotzke, M Saltzman, P Cresswell Molecular Immunology 150, 28, 2022 | | 2022 |
| Targeting SARS-CoV-2 Viral-immune Interaction for COVID-19 Therapy J Wang, Q Lu, J Liu, CB Huang, J Dong, Y Liu US Patent App. 17/484,483, 2022 | | 2022 |
| Mechanical activation of spike fosters SARS-CoV-2 infection (Aug, 10.1038/s41422-021-00576-9, 2021) W Hu, Y Zhang, P Fei, T Zhang, D Yao, Y Gao, J Liu, H Chen, Q Lu, ... CELL RESEARCH 31 (11), 1223-1223, 2021 | | 2021 |
| Author Correction: Mechanical activation of spike fosters SARS-CoV-2 infection W Hu, Y Zhang, P Fei, T Zhang, D Yao, Y Gao, J Liu, H Chen, Q Lu, ... Cell Research 31 (11), 1223, 2021 | | 2021 |
| Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy (vol 27, pg 680, 2021) J Sun, Q Lu, MF Sanmamed, J Wang CLINICAL CANCER RESEARCH 27 (13), 3804-3804, 2021 | | 2021 |
| Polymers for Transfection of mRNA: Polymer End Groups Dramatically Affect Efficiency and Biodistribution Y Jiang, Q Lu, Y Wang, T Agarwal, A Ho, E Xu, P Singh, Y Wang, Z Jiang, ... MOLECULAR THERAPY 27 (4), 183-184, 2019 | | 2019 |
